Ignyta (RXDX) Posts Q1 Loss of $1.15/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/28/2026

1. ENPH
2. HOOD
3. NXPI
4. BA
5. STX
6. V
7. CSGP
8. LSTR
9. UPS
10. KIDS

Go back to Ignyta (RXDX) Posts Q1 Loss of $1.15/Share

Ignyta Announces First Quarter 2015 Company Highlights and Financial Results

May 11, 2015 4:00 PM EDT

SAN DIEGO--(BUSINESS WIRE)-- Ignyta, Inc. (Nasdaq: RXDX), a precision oncology biotechnology company, today announced company highlights and financial results for the first quarter ended March 31, 2015.

We continue to make substantial progress toward our goal of becoming a leading precision oncology biotechnology company, and we are excited about our potential to develop first-in-class and best-in-class precision medicines to help cancer patients with unmet needs, said Jonathan Lim, M.D., Chairman and CEO of Ignyta. Our March 2015 acquisition of four development stage programs from Teva was transformational, enabling us to leverage our existing precision... More